Table 2.
Subtype | n | Percent of Subtype | Percent of Total | ||
---|---|---|---|---|---|
Phase I | Myelomeningocele | Community | 988 | 45.8 | 38.0 |
Household | 197 | 9.1 | 7.6 | ||
Therapeutic | 165 | 7.7 | 6.3 | ||
Wheelchair | 806 | 37.4 | 31.0 | ||
Total | 2156 | 100.0 | 82.8 | ||
Non-myelomeningocele | Community | 413 | 92.4 | 15.9 | |
Household | 11 | 2.5 | 0.4 | ||
Therapeutic | 8 | 1.8 | 0.3 | ||
Wheelchair | 15 | 3.4 | 0.6 | ||
Total | 447 | 100.0 | 17.2 | ||
Phase II | Myelomeningocele | Community | 140 | 43.3 | 36.8 |
Household | 34 | 10.5 | 8.9 | ||
Therapeutic | 29 | 9.0 | 7.6 | ||
Wheelchair | 120 | 37.2 | 31.6 | ||
Total | 323 | 100.0 | 85.0 | ||
Non-myelomeningocele | Community | 51 | 89.5 | 13.4 | |
Household | 3 | 5.3 | 0.8 | ||
Therapeutic | 1 | 1.8 | 0.3 | ||
Wheelchair | 2 | 3.5 | 0.5 | ||
Total | 57 | 100.0 | 15.0 |